What is Ibere Pharmaceuticals (IBER)?

Ibere Pharmaceuticals (IBER) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of IBER?

The current price of IBER is $10.18. Prices are updated in real time on Stocks360.

What is IBER's price-to-earnings (PE) ratio?

IBER's trailing twelve-month PE ratio is 29.94, based on current price and earnings per share data available on Stocks360.

What is IBER's market capitalization?

IBER's market capitalization is $175,605,000.00, placing it in the small-cap tier.

Ibere Pharmaceuticals (IBER)

Stock analysis · NYSE · Financial Services · Shell Companies

$10.18

Market Cap

$175.60M

PE (TTM)

29.94

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.00

Day Range

$10.18 – $10.18

52-wk Range

$9.75 – $10.75

Avg Volume

N/A

Volume

44.50K

Ibere Pharmaceuticals (IBER) is a publicly traded company in the Financial Services sector. Latest price: $10.18. Market cap $175.60M. Trailing PE 29.94. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Ibere Pharmaceuticals

Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	29.94×
P/S (TTM)	0.00×
P/B	0.92×
PEG	0.02×
P/FCF (TTM)	-202.14×
EV / EBITDA	-174.45×
EV / Sales	0.00×
Earnings Yield	1.33%
Free Cash Flow Yield	-0.49%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$175.15M
Net Income (TTM)	$2.34M
Free Cash Flow (TTM)	-$868.75K
Net Debt	-$458.39K
Working Capital	$320.94K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	2.46%
Return on Invested Capital	-0.73%